Translational research and innovative therapies


The Marseille Cancer Research Center celebrates its 50th anniversary ! -

The “Translational Research and Innovative Therapies” department at CRCM, led by Nelson Dusetti and Joseph Ciccolini, was established in 2022. It brings together five research teams collaborating with a diverse scientific advisory board comprising scientists, physicians, and pharmacologists. The department aims to facilitate collaboration between researchers and clinicians to develop operational clinical projects, create diagnostic tools, and enhance care for cancer patients.

The department’s activities focus on promoting multidisciplinary projects and translational research, supporting CRCM’s goal of bridging fundamental research with clinical applications. This close connection creates a virtuous cycle where clinical challenges drive research, benefiting patients through early trials.

Chair : Nelson Dusetti & Joseph Cicolini

Machine learning for precision oncology and drug design
Pedro Ballester

Team Pedro Ballester

Predictive oncology
François Bertucci & Emilie Mamessier

Team François Bertucci & Emilie Mamessier

Computational pharmacology and clinical oncology
Sébastien Benzekry & Joseph Ciccolini

Epithelial stem cells and cancer
Emmanuelle Charafe-Jauffret & Christophe Ginestier

Team Emmanuelle Charafe-Jauffret & Christophe Ginestier

Pancreatic cancer
Nelson Dusetti & Juan Iovanna

Team Nelson Dusetti & Juan Iovanna

Target discovery and innovative therapies in pediatric oncology
Nicolas André & Eddy Pasquier

Team Nicolas André & Eddy Pasquier